Viewing Study NCT03548220


Ignite Creation Date: 2025-12-25 @ 4:27 AM
Ignite Modification Date: 2026-02-26 @ 12:36 AM
Study NCT ID: NCT03548220
Status: COMPLETED
Last Update Posted: 2022-05-24
First Post: 2018-05-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)
Sponsor: Agios Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-08-09
Start Date Type: ACTUAL
Primary Completion Date: 2020-10-09
Primary Completion Date Type: ACTUAL
Completion Date: 2020-10-09
Completion Date Type: ACTUAL
First Submit Date: 2018-05-24
First Submit QC Date: None
Study First Post Date: 2018-06-07
Study First Post Date Type: ACTUAL
Results First Submit Date: 2021-10-08
Results First Submit QC Date: None
Results First Post Date: 2022-05-24
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-05-20
Last Update Post Date: 2022-05-24
Last Update Post Date Type: ACTUAL